Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Clinical trial NCT07430579 · RECRUITING

Trial details

NCT number: NCT07430579
Sponsor: The Second Hospital of Shandong University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pathological Complete Remission Objective Response Rate Immune-related Adverse Events Quality of Life

Start date: 2024-12-09
Primary completion: 2027-06-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.